CENTOGENE Reports First Quarter 2022 Financial Results
On Track for FY 2022 Guidance Q1 2022 revenue rises 3% to €10.3 million Completed phase out of COVID-19 Business...
Pharmaceutical
Key Points From The Healthcare BPO Market Analysis By The Business Research Company
The Business Research Company's healthcare BPO market research report expands on key drivers, trends, and growth opportunities in the market....
Consumer Confidence in Health Information from Non-Health Care Provider Sources on the Rise in The Harris Poll’s 2022 Health Information Trends Study
Trust in information from secondary sources like Internet searches, pharma companies, patient advocacy groups, and more has grown since 2019...
Cambridge Innovation Institute Announces the Acquisition of Evaluating Biopharma
Networking and Educational Event Series Join Cambridge Innovation Institute's Extensive Portfolio NEEDHAM, Mass., July 14, 2022 /PRNewswire/ -- Cambridge Innovation...
CMS Imaging Selected as Premier Value-Added Reseller for GE Edison™ True PACS
NORTH CHARLESTON, S.C., July 14, 2022 /PRNewswire/ -- CMS Imaging, Inc., a leading Independent Sales and Service Organization, has signed...
ZVerse Launches Early Access of its 3D Collaboration Platform Revaly
Nephron Pharmaceuticals Corporation selects Revaly as their design collaboration tool. WEST COLUMBIA, S.C., July 14, 2022 /PRNewswire/ -- ZVerse, an...
Digital Health Technologies Market to Garner USD 68.89 Billion by 2029: Industry Analysis by Technology, Application, Types, Key Segment, Challenges and Future Growth Prospects
MELBOURNE, Australia, July 14, 2022 /PRNewswire/ -- A Qualitative Research Study accomplished by Data Bridge Market research's database of 350...
Rune Labs Partners with Coastal Research Institute to Identify Biomarkers of Multiple Sclerosis Lesions using AI Platform to Analyze Patient Neurophysiological Data
Quantitative biomarkers of demyelination can improve clinical trial design and accelerate development of disease-modifying therapeutics SAN FRANCISCO, July 14, 2022...
Life Science Software Market Size, Share, Trends, Key Players, Revenue Outlook and Market to Gain USD 40.76 Billion by 2029
DURBAN, South Africa, July 14, 2022 /PRNewswire/ -- "Global Life Science Software Market" the new research report adds in Data Bridge...
Total Lab Automation Market Comprehensive Study Explores Huge Growth of USD 9.27 billion by 2029 With Share, Trends, Growth and Key Players Analysis
BERLIN, July 14, 2022 /PRNewswire/ -- Recent study report released by Data Bridge Market research with titled "Global Total Lab Automation Market" (covering...
Covis Pharma Group Announces Executive Leadership Appointment in Canada
ZUG, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets...
Triastek announces research collaboration with Lilly to explore the application of 3D printing technology in oral delivery of drugs
NANJING, China, July 13, 2022 /PRNewswire/ -- On July 13, 2022, Triastek, Inc. ("Triastek") announced a collaboration with Eli Lilly...
Apellis Announces Five Oral Presentations in Geographic Atrophy (GA) Highlighted at the ASRS Annual Scientific Meeting
WALTHAM, Mass., July 14, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in...
Horizon Technology Finance Provides Second Quarter 2022 Portfolio Update
- Horizon Platform Originates Record $192 Million of New Loans in Q2, Including $137 Million of New Loans for HRZN...
NervGen Pharma Closes US$15MM Private Placement and Appoints Dr. Adam Rogers to Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - July 14, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" the "Company"), a...
Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at Controlled Release Society 2022
Demonstrates OBDS Device Performance and Bioavailability in Animal ModelsSAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq:...
Chiesi tracks actions taken for a healthier, more sustainable future
Chiesi’s Annual and Sustainability Report 2021 is released today;Progress toward business, environmental and social targets is strong;Company is joining forces...
Xequel Bio Announces Positive Results from Phase 1b Study of iNexin™, a Novel aCT1 Ophthalmic Solution
Excellent Safety and Tolerability Profile for iNexin™ for the Treatment of Corneal Injury Early Efficacy Signals Provide Rationale to Advance...
MDbio Start Clinical Trials for Pharmaceutical-Grade Products That Target Sleeplessness, Anxiety and Pain; Expected Retail From 2023
Los Angeles, CA, July 14, 2022 (GLOBE NEWSWIRE) -- MDbio are a leading plant-based, wellness solution who provide safe, pharmaceutical-grade...
Allied Corp Successfully Ships Second Commercial Cannabis Flower Export From Colombia to International Market
KELOWNA, British Columbia, July 14, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...